7:00 AM-8:00 AM |
|
8:00 AM-5:00 PM |
|
8:00 AM–8:15 AM |
|
8:15 AM–9:10 AM |
|
9:10 AM–9:40 AM |
|
9:45 AM–11:30 AM |
Organized by the Student Affairs Committee,
Gary M. Shaw, Chairperson |
9:45 AM-10:00 AM |
5 |
Role of Retinoic Acid Receptor(y) in Regulating
the Expression of Genes Important in Chondrogenesis
and Cell Death in the Murine Limb |
|
|
Galdones E, Hales BF. Department of Pharmacology
and Therapeutics, McGill University, Montreal, QC, Canada. |
10:00 AM-10:15 AM |
6 |
Human Embryo Atlas Constructed by Magnetic Resonance
(MR) Imaging and Episcopic Fluorescence Image Capture
(EFIC) from the Kyoto Collection of Human Embryos |
|
|
Yamada S1,2, Anderson SA1, Lockett E3, Uwabe C2,
Shiota K2, Lo CW1. 1National Heart, Lung and Blood Institute,
National Institutes of Health, Bethesda, MD, United
States, 2Congenital Anomaly Research Center, Kyoto University
Graduate School of Medicine, Kyoto, Japan, 3National
Museum of Health & Medicine, Human Developmental Anatomy
Center, Washington, DC, United States. |
10:15 AM-10:30AM |
7 |
Low Nitric Oxide Availability is a Key Factor Underlying
Copper Deficiency Teratogenicity |
|
|
Yang SJ, Lanoue L, Keen CL, Rucker RB, Uriu-Adams
JY. University of California, Davis, Davis, CA, United
States. |
10:30 AM-10:45 AM |
|
Break |
10:45 AM-11:00 AM |
8 |
Release of p53 from Mitochondrial Matrix to the Nucleus
During Cellular Stress: Influence of PK11195 |
|
|
Green ML, Singh AV, Knudsen TB. University of
Louisville, Louisville, KY, United States. |
11:00 AM-11:15 AM |
9 |
Does the Risk of Spontaneous Abortion Differ by Prenatal
Exposure to Wine, Spirits or Beer? |
|
|
Ammon LN1,2, Kaskutas LA1,2, Li DK3. 1University
of California Berkeley, School of Public Health, Deparment
of Epidemiology, Berkeley, CA, United States, 2Alcohol
Research Group, Emerville, CA, United States, 3Kaiser
Permanente, Division of Research, Oakland, CA, United
States. |
11:15 AM-11:30 AM |
10 |
Changes in Placental Th1 Cytokines and Apoptosis After
Infection of Guinea Pigs With Listeria Monocytogenes |
|
|
Irvin EA1,2, Williams D1, Jensen A1,3, Richardson
AN1, Smith MA1,2. 1Department of Environmental Health
Science, Athens, GA, United States, 2Center for Food
Safety, Griffin, GA, United States, 3Danish Institute
for Fisheries Research, Denmark. |
|
|
11:30 AM-12:30 PM |
|
11:30 AM-1:00 PM |
|
11:30 AM–1:00
PM |
(By Invitation Only) |
|
|
1:00 PM–2:00 PM |
Sponsored by Charles River Laboratories,
Inc. Speaker:
Kenneth Lyons Jones, University of California, San Diego |
|
|
2:00 PM–5:30 PM |
Chairpersons: Dee L. Quinn, University
of Arizona and Judith A. Wubah, James Madison University
2:00 PM-2:35 PM |
S5 |
Measuring Worldwide Incidence of FASD |
|
|
Speaker: Christina D. Chambers, University of
California, San Diego |
2:35 PM-3:10 PM |
S6 |
Effects of Prenatal Alcohol Exposure on Brain and
Behavior |
|
|
Speaker: Edward P. Riley, San Diego State University |
3:10 PM-3:45 PM |
S7 |
Functional Imaging Studies of Cognitive Outcomes in
FASD |
|
|
Speaker: Jennifer A. Willford, University of Pittsburgh |
3:45 PM-4:05 PM |
|
Break |
4:05 PM-4:40 PM |
S8 |
Outcomes of Pregnancies Exposed to Low to Moderate
Levels of Alcohol |
|
|
Speaker: Nancy L. Day, University of Pittsburgh |
4:40 PM-5:15 PM |
S9 |
Imaging and Mechanism Studies in an FASD Mouse Model |
|
|
Speaker: Kathleen Sulik, University of North Carolina
at Chapel Hill |
5:15 PM-5:30 PM |
|
Discussion |
|
|
|
2:00 PM–5:30 PM |
|
Chairpersons:
Barbara Hales, McGill University and Michael F. O'Hara, Novartis
Pharmaceuticals
2:00 PM-2:15 PM |
11 |
Developmental Toxicity Signals Observed
for 17á-Hydroxyprogesterone Caproate in High Risk Pregnancies
in the Non-Clinical Literature for Developmental Toxicity
of Progestins |
|
|
Christian MS1, Brent RL2, Calda P3. 1Argus International,Inc.,
Horsham, PA, United States, 2Jefferson Medical College
and duPont Hospital for Children, Wilmington, DE, United
States, 3Charles University, First Medical School, Department
of Obstetrics and Gynecology, Prague, Czech Republic. |
2:15 PM-2:30 PM |
12 |
Risk of Major Malformations Among Infants Exposed
to Carbamazepine During Pregnancy |
|
|
Hernandez-Diaz S2, Smith CR1, Wyszynski DF3, Holmes
LB1. 1MassGeneral Hospital for Children, Boston, MA,
United States, 2Harvard School of Public Health, Boston,
MA, United States, 3Boston University School of Medicine,
Boston, MA, United States. |
2:30 PM-2:45 PM |
13 |
Paroxetine Use in Pregnancy: Is There an Association
With Congenital Cardiovascular Defects? |
|
|
Einarson A1, Pistelli A2, Desantis M3, Malm H4,
Paulus WE5, Panchaud A6, Kennedy D7, Einarson TR1,8,
Koren G1. 1The Motherisk Program, The Hospital for Sick
Children, Toronto, ON, Canada, 2Servizio di Tossicologia
Perinatale, Firenze, Italy, 3Telefona Rosa, Rome, Italy,
4Teratology Information Service, Helsinki, Finland,
5Teratology Information Service, Ravensburg, Germany,
6Swiss Teratogen Information Service, Lausanne, Switzerland,
7The Mothersafe Program, Sydney, Australia, 8Leslie
Dan Faculty of Pharmacy, University of Toronto, Toronto,
ON, Canada, 9The Motherisk Program, Toronto, ON, Canada. |
2:45 PM-3:00 PM |
14 |
Duration of Antidepressant Use During Pregnancy and
Risk of Major Congenital Malformations |
|
|
Ramos E1,2, St-Andre M1,2, Rey E1,2, Oraichi D2,
Berard A1,2. 1University of Montreal, Montreal, QC,
Canada, 2CHU Sainte-Justine, Montreal, QC, Canada. |
3:00 PM-3:15 PM |
15 |
Neurodevelopment After Prenatal Exposure to Antidepressant
Medication |
|
|
Pedersen LH1,2, Henriksen TB2, Olsen J3. 1The
Danish Epidemiology Science Center, Institute of Public
Health, University of Aarhus, Aarhus, Denmark, 2Perinatal
Epidemiology Research Unit, Department of Pediatrics,
Aarhus University Hospital, Aarhus, Denmark, 3UCLA School
of Public Health, Department of Epidemiology, Los Angeles,
CA, United States. |
3:15 PM-3:30 PM |
16 |
Nutrient Intakes in Women and Congenital Diaphragmatic
Hernia in Their Offspring |
|
|
Yang W1, Shaw GM1, Carmichael SL1, Rasmussen SA2,
Waller DK3, Pober BR4,5, Anderka M6. 1California Birth
Defect Monitoring Program, Berkeley, CA, United States,
2Centers for Disease Control and Prevention, Atlanta,
GA, United States, 3School of Public Health, University
of Texas Health Science Center, Houston, TX, United
States, 4MassGeneral Hospital for Children, Boston,
MA, United States, 5Children's Hospital, Boston, MA,
United States, 6Bureau of Family and Community Health,
Massachusetts Department of Public Health, Boston, MA,
United States. |
3:30 PM-3:45 PM |
17 |
Maternal Folate, Vitamin B-6, and Homocysteine Levels
and Risk of Oral Clefts in Utah |
|
|
Munger RG1, Johnson KE2, Feldkamp M3, Phister
R1, Cutler DR1, Botto L4, Carey J4, Tamura T2. 1Utah
State University, Logan, UT, United States, 2University
of Alabama at Birmingham, Birmingham, AL, United States,
3Utah Department of Health, Salt Lake City, UT, United
States, 4University of Utah, Salt Lake City, UT, United
States. |
3:45 PM-4:00 PM |
|
Break |
4:00 PM-4:15 PM |
18 |
Ventilatory Response to Hypercapnia in Rats Exposed
to Fluoxetine In Utero |
|
|
Boucher N1,2, Saad N1,2, Joseph V2, Beaulac-Baillargeon
L1,2. 1Laval University, Faculty of Pharmacy, Quebec,
QC, Canada, 2CHUQ Research Center, Perinatalogy Unit,
Quebec, QC, Canada. |
4:15 PM-4:30 PM |
19 |
Skeletal Anomalies in Novel Mutant Mouse Models With
Congenital Cardiac Anomalies |
|
|
Gibbs BC1,
Schimel D2,
YuQ, Lo CW1.
1Laboratory
of Developmental Biology, NHLBI/NIH, and 2Mouse
Imaging Facility, NINDS/NIH Bethesda, MD, USA |
4:30 PM-4:45 PM |
20 |
Dihydroartemisinin (DHA) Treatment Causes Decreased
Proliferation and Apoptosis in Rat Embryonic Erythroblasts
in Whole Embryo Culture |
|
|
Posobiec LM, Bushdid PB, Laffan SB, Clark RC,
White TE. Safety Assessment, GlaxoSmithKline, King of
Prussia, PA, United States. |
4:45 PM-5:00 PM |
21 |
Autoradiography Reveals Specific Labeling of Embryonic
and Fetal Red Blood Cells by the Anti-Malarial, Artesunate |
|
|
White TE1, Lordi AW2, Bushdid PB1, Cox EM1, Floyd
LE1, Fishman CE1, Solon EG2, Clark RL1. 1GlaxoSmithKline,
King of Prussia, PA, United States, 2Quest Pharmaceutical
Services, LLC, Newark, DE, United States. |
5:00 PM-5:15 PM |
22 |
Craniosynostosis and Maternal Smoking |
|
|
Carmichael SL1, Ma C1, Rasmussen SA2, Honein MA2,
Lammer EJ3, Shaw GM1. 1March of Dimes, California Birth
Defects Monitoring Program, Berkeley, CA, United States,
2National Center on Birth Defects and Developmental
Disabilities, Centers for Disease Control and Prevention,
Atlanta, GA, United States, 3Children's Hospital Research
Institute, Oakland, CA, United States. |
5:15 PM-5:30 PM |
23 |
Pregnancy Outcome Following Early Gestational Exposure
to Leflunomide |
|
|
Chambers CD, Jones KL, Johnson DL, OTIS Collaborative
Research Group. University of California San Diego,
La Jolla, CA, United States. |
|
|
|
5:30 PM–7:30 PM |
Sponsored by Covance, Endo Pharmaceuticals, and Noblis, Inc.
|
|
|
7:30 PM–10:30 PM |
Sponsored by MTA / MARTA |
rev. 24-April, 2007
© Copyright Society for Birth Defects Research and Prevention
1998-2006, 2007.
Please read our disclaimer.
|